Of the participants who had DBS samples collected and analyzed, 6% (n = 10) were found to have high adherence (~7 doses per week), 20% (n = 35) had medium adherence (~2 to 5 doses per week), 23% (n = 40) had low adherence (<2 doses per week), and 51% (n =90) either had unquantifiable TFV-DP concentration levels or did not report using PrEP in the last 30 days during the 3-month visit. In the last 30 days during the 6-month visit, 1% (n = 1) were found to have high adherence, 5% (n = 5) had medium adherence, 14% (n = 15) had low adherence, and 80% (n = 80) had unquantifiable TFV-DP concentration levels or did not report using PrEP.
In addition, 96% of pregnant AGYW were sexually active at baseline. Approximately 68% and 71% continued to be sexually active at the 3- and 6-month follow-ups, respectively. A higher proportion of adolescent girls (75%) reported sexual abstinence during the postpartum period compared to young women (52%); however, by 6 months, the frequency of sexual activity during the postpartum period was similar for both groups. Further, adolescent girls with no perceived HIV risk reported sexual abstinence at 3 months (55%), whereas young girls with no perceived HIV risk had a lower rate of sexual abstinence (28%).
Although the proportions of AGYW who were pregnant and postpartum that initiated PrEP at baseline were similar (82% vs 83%, respectively), the percentage of continuation at 1 month (56% vs 66%, respectively), 3 months (45% vs 59%, respectively), and 6 months (34% vs 42%, respectively) was higher among those with greater HIV baseline risk scores compared with those with lower risk scores; however, the proportion of those with any TFV-DP concentration levels detected in DBS samples was similar at 3 months (48% vs 49%, respectively) and 6 months (14% vs 22%, respectively).
Limitations of the study include the collection of PrEP-PP data from 1 urban ANC clinic resulting in a lack of generalizability and potential self-report errors due to social desirability bias. Adherence levels were marked by the investigators as missing or unknown for those who reported using PrEP but did not have their DBS analyzed later in the study. Further, low adherence to PrEP among AGYW could be due to changing HIV risks.
The findings suggest the existence of key barriers in HIV prevention methods for AGYW who began ANC visits later and had a high burden of untreated STIs, according to the study authors. Further, they recommend that HIV and PrEP counseling should be integrated into ante- and postpartum care and community delivery to simplify PrEP delivery among women who are pregnant.
Reference
Khadka N, Gorbach PM, Nyemba D, et al. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa. Front Reprod Health. 2023;5. doi: 10.3389/frph.2023.1224474